CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced the extension of ...

In a significant move towards enhancing product quality and safety, Astron Limited has successfully secured the ISO 9001:2015 ...

Passengers can now book flights to over 40 destinations across Loganair’s 70-route network as part of its winter schedule ...

Regional carrier Loganair has put more than one million seats on sale for its winter schedule, operating from October to next ...

# Bahamasair’s managing director yesterday said a newly-acquired ATR aircraft is on route to The Bahamas to give the national flag carrier a much-needed fleet boost. # Tracy Cooper added that the 70 ...

Walrus (WAL) had a successful airdrop on March 27. The WAL price fell after its launch but rallied on March 29. Will WAL ...

Q4 2024 Earnings Call Transcript March 31, 2025 Cytosorbents Corporation beats earnings expectations. Reported EPS is $-0.03, ...

Cytosorbents Corporation (CTSO) reports 25% Q4 revenue growth, strong margins, and updates on FDA-reviewed DrugSorb-ATR launch.

CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the ...